Patient info Open main menu

Zaditen tablets 1 mg – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
1 mg
Contains active substance:
ATC code:

Patient leaflet - Zaditen tablets 1 mg

1. What Zaditen Tablets are and what they are used for

Zaditen Tablets contains the active ingredient, ketotifen. Ketotifen is an antihistamine with anti-allergy properties.

In allergic conditions certain substances are released in the body. These trigger inflammatory responses. Zaditen Tablets act to dampen down these responses and can therefore be used to treat various allergic conditions such as rhinitis (inflammation of the mucous membranes in the nose) and conjunctivitis (inflammation of the mucous membranes in the eye).

2. What you need to know before you take Zaditen Tablets

Do not take Zaditen Tablets:

  • If you are allergic to ketotifen or to any of the other ingredients of this medicine (listed on section 6).
  • If you are taking any oral medicines for diabetes.
  • If you are breast-feeding.
  • If you have epilepsy.

Warnings and precautions

Talk to your doctor or pharmacist before taking Zaditen Tablets:

  • Zaditen Tablets are not effective in preventing or treating acute asthma attacks.
  • Do not stop taking other asthma medications unless your doctor tells you to, however well you feel.
  • During the first few days of treatment your reactions may be impaired (i.e. you may feel drowsy or your reactions may be slower than usual, even if you do not feel drowsy). You should not take charge of vehicles or machinery until the effect of your medicine on your reactions is known. Your doctor may reduce the dose if your reactions are slowed.
  • Zaditen Tablets may increase the effects of sedatives, anti-histamines, medicines used to treat depression or anxiety, anticoagulants to reduce the ability of the blood to clot and alcohol.

    • As Zaditen Tablets may lower the seizure threshold it should be used with caution in patients with a history of epilepsy. Convulsions have been reported very rarely during Zaditen therapy
    • Symptomatic and prophylactic anti-asthmatic drugs already in use should never be stopped abruptly when long-term treatment with Zaditen is started.
    • A reversible fall in the thrombocyte count in patients receiving Zaditen concomitantly with oral antidiabetic agents (biguanides) has been observed in rare cases. The simultaneous administration of these drugs should therefore be avoided.
    • if you are epileptic.

Other medicines and Zaditen Tablets

Some medicines can interfere with your treatment. Make sure your doctor knows if you are taking or have recently taken any other medicines, including medicines obtained without a prescription:

  • if you are taking any oral medicines for diabetes
  • if you are taking any other medicines for asthma
  • if you are taking any medicines to treat sleeplessness or anxiety or medicines to treat depression
  • if you are taking anti-histamines to treat allergic reactions such as itching, rash or runny nose
  • if you are taking any anticoagulants to reduce the ability of the blood to clot
  • if you are taking any hypnotics.

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Zaditen Tablets with food and alcohol

You should take Zaditen Tablets with food. The effects of alcohol may be increased by Zaditen Tablets. Do not drink alcohol when you are taking them.

Pregnancy, breastfeeding and fertility

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

It is not recommended to take Zaditen Tablets during pregnancy. If you become pregnant whilst taking Zaditen Tablets, tell your doctor. Ketotifen is excreted in breast milk; therefore mothers receiving Zaditen Tablets should not breast-feed.

Driving and using machines

During the first few days of treatment you may feel that your reactions are slower than usual. Some people can feel drowsy or dizzy. If you are affected in any way you should not drive or do anything that requires you to be alert (such as operate tools or machinery) until any problems clear up.

Zaditen Tablets contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

3. How to take Zaditen Tablets

Always take this medicine exactly as your doctor or pharmacist has told you to. Check with your doctor or pharmacist if you are not sure. The doctor will decide what dose of Zaditen Tablets you should take. Check the label carefully. It should tell you how many tablets to take, and how often. Keep taking the tablets for as long as you have been told unless you have any problems. In that case, check with your doctor.

Swallow the tablets with a drink of water. Take them at the same time as you are eating. Patient leaflet: information for the patient

ZADITEN Tablets 1 mg

(ketotifen)

Adults

The usual dose is 1 or 2 mg (1 or 2 tablets) twice a day with food.

Children (aged over 3 years and adolescents)

The usual dose is 1 mg (1 tablet) twice a day with food.

Zaditen Tablets should not be given to children under 3 years of age.

For patients for whom a tablet form may not be suitable, an alternative dosage form should be considered.

The doctor may decide to start with a lower dose.

If you forget to take Zaditen Tablets

If you forget to take a dose of Zaditen, take another one as soon as you remember, unless it is almost time for your next dose. If it is almost time for your next dose, just take the next dose as you would do normally and miss out the tablets that you have forgotten to take. Do not take a double dose of Zaditen to make up for a forgotten dose.

If you take more Zaditen Tablets you should

All tablets can be risky if you take too many. If you accidentally take too many Zaditen Tablets, tell your doctor or hospital casualty department as soon as possible. Take your medicine pack with you so that people can see what you have taken.

If you stop taking Zaditen Tablets

Do not stop taking Zaditen Tablets unless your doctor tells you to, however well you feel. Discontinuation of treatment should take place gradually over a 2 to 4 week period. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Some side effects can be serious.

Stop taking the tablets and tell your doctor immediately if you notice any of the following very rare symptoms (likely to affect fewer than 1 of every 10,000 patients):

  • If you have skin rash, redness of the skin, blistering of the lips, eyes and mouth accompanied with fever, chills, headache, cough and body aches
  • If you have a yellowing of the skin and eyes, coloured bowel motions, dark coloured urine (signs of jaundice, liver disorder, hepatitis) Tell your doctor immediately if you have a fit (convulsions).

The side effects listed below have also been reported:

Common side effects: may affect up to 1 in 10 people

  • Agitation
  • Irritability
  • Inability to sleep (insomnia)
  • Nervousness

Uncommon side effects: may affect up to 1 in 100 people

  • Dizziness
  • Burning sensation when passing urine and need to urinate frequently and urgently (cystitis)
  • Dry mouth

Rare side effects: may affect up to 1 in 1,000 people

  • Drowsiness
  • Weight increased

    Not known: frequency cannot be estimated from the available data

    • Somnolence
    • Headache
    • Vomiting
    • Nausea
    • Diarrhoea

Other side effects that have been reported are feeling sick or being sick, headache, convulsions (fits), urticaria (hives) or rash.

The sleepiness, dry mouth and dizziness usually go away a few days after you have started taking Zaditen.

Symptoms of CNS stimulation, such as agitation, irritability, insomnia, and nervousness, have been observed particularly in children.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Zaditen Tablets

Keep your tablets in the foil. Only remove them when it is time to take your medicine. Store below 25oC.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the outside of the pack. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Content of the pack and other information

What Zaditen Tablets contains

The active substance is ketotifen (as the hydrogen fumarate). Each tablet contains 1 mg of ketotifen. The other ingredients are magnesium stearate, pre-gelatinised corn starch, lactose and maize starch.

What Zaditen Tablets looks like and content of the pack

Zaditen Tablets 1 mg are white, flat tablets with a break line on one side.

The tablets come in blister packs of 60.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Alfasigma S.p.A.

Via Ragazzi del ‘99, n. 5

40133 Bologna (BO), Italy

Manufacturer

Mipharm S.p.A.,

Via Bernardo Quaranta, 12, 20141 Milan (MI), Italy Local representative

CD Pharmaceuticals AB

Ulls väg 29A - 756 51 Uppsala - Sweden

This leaflet was revised in February 2024.

45004904 934394 UK

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 48053/0008

Last revision stated in the text: February 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Zaditen tablets 1 mg

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Ketotifen
Strength 1 mg
Pharmaceutical form Oral tablet
How is it taken Oral
Pack sizes 60 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. R Respiratory system drugs
    1. R06 Antihistamines for systemic use
      1. R06A Antihistamines for systemic use
        1. R06AX Other antihistamines for systemic use
          1. R06AX17 ketotifen
Marketing authorisation PL 48053/0008
Codes GTIN 8051499762414 · BNF 03040100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.